These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 32526753)
1. Tissue-Infiltrating Lymphocytes as a Predictive Factor for Recurrence in Patients with Curatively Resected Colon Cancer: A Propensity Score Matching Analysis. Chan LF; Sadahiro S; Suzuki T; Okada K; Miyakita H; Yamamoto S; Kajiwara H Oncology; 2020; 98(10):680-688. PubMed ID: 32526753 [TBL] [Abstract][Full Text] [Related]
2. Clinical impact of tumor-infiltrating lymphocytes for survival in curatively resected stage IV colon cancer with isolated liver or lung metastasis. Lee WS; Kang M; Baek JH; Lee JI; Ha SY Ann Surg Oncol; 2013 Feb; 20(2):697-702. PubMed ID: 23224827 [TBL] [Abstract][Full Text] [Related]
3. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer. Wang K; Shen T; Siegal GP; Wei S Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275 [TBL] [Abstract][Full Text] [Related]
4. Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy. Turksma AW; Coupé VM; Shamier MC; Lam KL; de Weger VA; Belien JA; van den Eertwegh AJ; Meijer GA; Meijer CJ; Hooijberg E Clin Cancer Res; 2016 Jan; 22(2):346-56. PubMed ID: 26420855 [TBL] [Abstract][Full Text] [Related]
5. Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes. Zlobec I; Terracciano LM; Lugli A Clin Cancer Res; 2008 Jun; 14(12):3792-7. PubMed ID: 18559598 [TBL] [Abstract][Full Text] [Related]
6. A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment. Lea D; Watson M; Skaland I; Hagland HR; Lillesand M; Gudlaugsson E; Søreide K Cancer Immunol Immunother; 2021 Jul; 70(7):2049-2057. PubMed ID: 33439293 [TBL] [Abstract][Full Text] [Related]
7. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1 Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701 [TBL] [Abstract][Full Text] [Related]
8. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study. Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis. Ibrahim EM; Al-Foheidi ME; Al-Mansour MM; Kazkaz GA Breast Cancer Res Treat; 2014 Dec; 148(3):467-76. PubMed ID: 25361613 [TBL] [Abstract][Full Text] [Related]
10. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients. Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288 [TBL] [Abstract][Full Text] [Related]
11. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response. Shin SJ; Kim SY; Choi YY; Son T; Cheong JH; Hyung WJ; Noh SH; Park CG; Kim HI Oncologist; 2019 Sep; 24(9):e835-e844. PubMed ID: 30894409 [TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer. Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756 [TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast. Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A BMC Cancer; 2021 Mar; 21(1):286. PubMed ID: 33726701 [TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer. Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128 [TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers. Kim KJ; Lee KS; Cho HJ; Kim YH; Yang HK; Kim WH; Kang GH Hum Pathol; 2014 Feb; 45(2):285-93. PubMed ID: 24331841 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer. Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145 [TBL] [Abstract][Full Text] [Related]
18. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells). Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance. Althobiti M; Aleskandarany MA; Joseph C; Toss M; Mongan N; Diez-Rodriguez M; Nolan CC; Ashankyty I; Ellis IO; Green AR; Rakha EA Histopathology; 2018 Dec; 73(6):887-896. PubMed ID: 29947077 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer. Kinoshita T; Muramatsu R; Fujita T; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Kudo-Saito C; Hayashi Y; Kamiyama I; Ohtsuka T; Asamura H; Kawakami Y Ann Oncol; 2016 Nov; 27(11):2117-2123. PubMed ID: 27502728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]